$PCRX
Pacira BioSciences, Inc. Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2011 Q4 Form 10-K Financial Statement

#000104746913002336 Filed on March 07, 2013

Income Statement

Concept	2011 Q4	2011 Q1	2010 Q4
Revenue	$4.200M	$3.863M	$2.200M
YoY Change	90.91%	-19.52%	-48.84%
Cost Of Revenue	$6.600M	$3.667M	$2.100M
YoY Change	214.29%	-0.89%	-40.0%
Gross Profit	-$2.400M	$196.0K	$100.0K
YoY Change	-2500.0%	-80.4%	-87.5%
Gross Profit Margin	-57.14%	5.07%	4.55%
Selling, General & Admin	$7.200M	$3.523M	$2.400M
YoY Change	200.0%	252.3%	118.18%
% of Gross Profit		1797.45%	2400.0%
Research & Development	$2.100M	$3.795M	$3.700M
YoY Change	-43.24%	-17.5%	-50.67%
% of Gross Profit		1936.22%	3700.0%
Depreciation & Amortization	$1.280M	$990.0K	$1.000M
YoY Change	28.0%	-3.88%	-1.96%
% of Gross Profit		505.1%	1000.0%
Operating Expenses	$9.400M	$10.99M	$6.100M
YoY Change	54.1%	92.72%	-29.07%
Operating Profit	-$11.80M	-$7.122M	-$6.000M
YoY Change	96.67%	51.53%	-23.08%
Interest Expense	-$600.0K	$2.481M	-$1.300M
YoY Change	-53.85%	-513.5%	85.71%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$2.653M	$500.0K
YoY Change	-100.0%	1226.5%	-200.0%
Pretax Income	-$15.30M	-$9.800M	-$7.000M
YoY Change	118.57%	81.48%	-22.22%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$15.30M	-$9.775M	-$7.000M
YoY Change	118.57%	81.02%	-22.22%
Net Earnings / Revenue	-364.29%	-253.04%	-318.18%
Basic Earnings Per Share
Diluted Earnings Per Share	-$624.5K	-$980.0K	-$407.0K
COMMON SHARES
Basic Shares Outstanding	17.23M shares	10.01M shares
Diluted Shares Outstanding		10.01M shares

Balance Sheet

Concept	2011 Q4	2011 Q1	2010 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$76.20M	$59.30M	$26.10M
YoY Change	191.95%
Cash & Equivalents	$46.17M	$59.33M	$26.13M
Short-Term Investments	$30.00M		$0.00
Other Short-Term Assets	$3.100M	$1.100M	$2.100M
YoY Change	47.62%
Inventory	$1.245M	$1.800M	$1.605M
Prepaid Expenses
Receivables	$2.113M	$1.800M	$1.191M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$82.65M	$64.00M	$31.06M
YoY Change	166.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.10M	$24.40M	$23.95M
YoY Change	4.81%
Goodwill	$0.00
YoY Change
Intangibles	$5.259M		$8.912M
YoY Change	-40.99%
Long-Term Investments
YoY Change
Other Assets	$479.0K	$1.100M	$2.645M
YoY Change	-81.89%
Total Long-Term Assets	$30.84M	$33.90M	$35.51M
YoY Change	-13.14%
TOTAL ASSETS
Total Short-Term Assets	$82.65M	$64.00M	$31.06M
Total Long-Term Assets	$30.84M	$33.90M	$35.51M
Total Assets	$113.5M	$97.90M	$66.56M
YoY Change	70.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.440M	$6.100M	$4.315M
YoY Change	-20.28%
Accrued Expenses	$7.159M	$3.800M	$4.983M
YoY Change	43.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.039M	$7.200M	$3.182M
YoY Change	121.21%
Total Short-Term Liabilities	$31.91M	$19.70M	$16.32M
YoY Change	95.51%
LONG-TERM LIABILITIES
Long-Term Debt	$18.54M	$22.40M	$21.87M
YoY Change	-15.24%
Other Long-Term Liabilities	$2.778M	$24.60M	$3.783M
YoY Change	-26.57%
Total Long-Term Liabilities	$21.32M	$47.00M	$25.65M
YoY Change	-16.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.91M	$19.70M	$16.32M
Total Long-Term Liabilities	$21.32M	$47.00M	$25.65M
Total Liabilities	$65.22M	$66.70M	$114.9M
YoY Change	-43.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$180.2M		-$136.9M
YoY Change	31.65%
Common Stock	$25.00K		$1.000K
YoY Change	2400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.000K		$2.000K
YoY Change	0.0%
Treasury Stock Shares	1.065K shares		1.065K shares
Shareholders Equity	$48.27M	$31.10M	-$48.38M
YoY Change
Total Liabilities & Shareholders Equity	$113.5M	$97.90M	$66.56M
YoY Change	70.5%

Cashflow Statement

Concept	2011 Q4	2011 Q1	2010 Q4
OPERATING ACTIVITIES
Net Income	-$15.30M	-$9.775M	-$7.000M
YoY Change	118.57%	81.02%	-22.22%
Depreciation, Depletion And Amortization	$1.280M	$990.0K	$1.000M
YoY Change	28.0%	-3.88%	-1.96%
Cash From Operating Activities	-$7.600M	-$3.990M	-$5.840M
YoY Change	30.14%	10.83%	-795.24%
INVESTING ACTIVITIES
Capital Expenditures	-$2.490M	-$830.0K	-$2.950M
YoY Change	-15.59%	97.62%	637.5%
Acquisitions
YoY Change
Other Investing Activities	-$9.290M	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$11.76M	-$830.0K	-$2.950M
YoY Change	298.64%	97.62%	637.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$49.00M	$37.10M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	49.13M	38.02M	21.07M
YoY Change	133.18%	406.93%	844.84%
NET CHANGE
Cash From Operating Activities	-7.600M	-3.990M	-5.840M
Cash From Investing Activities	-11.76M	-830.0K	-2.950M
Cash From Financing Activities	49.13M	38.02M	21.07M
Net Change In Cash	29.77M	33.20M	12.28M
YoY Change	142.43%	854.02%	359.93%
FREE CASH FLOW
Cash From Operating Activities	-$7.600M	-$3.990M	-$5.840M
Capital Expenditures	-$2.490M	-$830.0K	-$2.950M
Free Cash Flow	-$5.110M	-$3.160M	-$2.890M
YoY Change	76.82%	-0.63%	-333.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2012	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2012	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2012	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2012Q4	us-gaap	Assets Current AssetsCurrent	60922000	USD
CY2012Q4	us-gaap	Assets Assets	112054000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14156000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	46199000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	65855000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112054000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46168000	USD
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1299000	USD
CY2011Q4	us-gaap	Short Term Investments ShortTermInvestments	29985000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2113000	USD
CY2011Q4	us-gaap	Inventory Net InventoryNet	1245000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1839000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	82649000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25103000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5259000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	479000	USD
CY2011Q4	us-gaap	Assets Assets	113490000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3440000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7159000	USD
CY2011Q4	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	1219000	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13054000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7039000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31911000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18537000	USD
CY2011Q4	pcrx	Royalty Interest Obligation Noncurrent RoyaltyInterestObligationNoncurrent	1537000	USD
CY2011Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8416000	USD
CY2011Q4	pcrx	Contingent Purchase Liability ContingentPurchaseLiability	2042000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2778000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	65221000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	33000	USD
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25339038	shares
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18628000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-43328000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	228470000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180239000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	15000	USD
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	48269000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	113490000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	25000	USD
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32624049	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32622984	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25340103	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1065	shares
CY2011Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1065	shares
CY2011	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	5074000	USD
CY2011	us-gaap	Revenues Revenues	15689000	USD
CY2010	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3217000	USD
CY2010	us-gaap	Revenues Revenues	14562000	USD
CY2012	us-gaap	Revenues Revenues	39084000	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	88382000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-49298000	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.72
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	30331965	shares
CY2011	us-gaap	Cost Of Revenue CostOfRevenue	16739000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14873000	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2983000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-52281000	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20159000	USD
CY2011	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	3019000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	54790000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-39101000	USD
CY2010	us-gaap	Cost Of Revenue CostOfRevenue	12276000	USD
CY2010	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6367000	USD
CY2010	us-gaap	Operating Expenses OperatingExpenses	37271000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-22709000	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	255000	USD
CY2011	us-gaap	Interest Expense InterestExpense	4780000	USD
CY2011	us-gaap	Royalty Expense RoyaltyExpense	-227000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	71000	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4227000	USD
CY2010	us-gaap	Royalty Expense RoyaltyExpense	930000	USD
CY2010	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-184000	USD
CY2010	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	487000	USD
CY2010	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4440000	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-27149000	USD
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.64
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1065000	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	135000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2493000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37109000	USD
CY2011	pcrx	Stock Issued During Period Value Follow On Public Offering Issues StockIssuedDuringPeriodValueFollowOnPublicOfferingIssues	49006000	USD
CY2010	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-47.29
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16437464	shares
CY2010	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	574072	shares
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	-22949000	USD
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23000	USD
CY2010	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1692000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-70130000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-29522000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	63610000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4314000	USD
CY2011	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-273000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	2493000	USD
CY2011	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	-85000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4071000	USD
CY2010	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	-149000	USD
CY2010	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-11000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	23000	USD
CY2011	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-14000	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	922000	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-360000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	608000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2549000	USD
CY2011	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	27000	USD
CY2010	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	98000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31000000	USD
CY2010	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-264000	USD
CY2010	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-124000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-32000	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1118000	USD
CY2010	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2328000	USD
CY2010	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1782000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-24880000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6167000	USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	14000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62855000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-36123000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6770000	USD
CY2010	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-6769000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	136000	USD
CY2011	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	38016000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49006000	USD
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	USD
CY2010	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	87158000	USD
CY2010	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	7500000	USD
CY2010	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	56250000	USD
CY2010	us-gaap	Repayments Of Debt RepaymentsOfDebt	11250000	USD
CY2010	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1795000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	50705000	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	20035000	USD
CY2010	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	19056000	USD
CY2010	us-gaap	Interest Paid InterestPaid	2371000	USD
CY2010	pcrx	Debt Conversion Converted Instrument Amount Two DebtConversionConvertedInstrumentAmountTwo	1692000	USD
CY2010	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	500000	USD
CY2012	us-gaap	Interest Paid InterestPaid	4229000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5648000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7077000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26133000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10126000	USD
CY2012	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <p style="FONT-FAMILY: times"><font size="2"><b>NOTE 3—RECENT ACCOUNTING PRONOUNCEMENTS</b></font></p> <p style="FONT-FAMILY: times"><font size="2">        In February 2013, the Financial Accounting Standards Board, or FASB, issued amendments to the accounting guidance for presentation of comprehensive income to improve the reporting of reclassifications out of accumulated other comprehensive income. The amendments do not change the current requirements for reporting net income or other comprehensive income, but do require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where the net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about these amounts. These amendments are effective prospectively for reporting periods beginning after December 15, 2012. The Company does not believe the adoption of this guidance will have a material impact on the consolidated financial statements.</font></p> <p style="FONT-FAMILY: times"><font size="2">        Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.</font></p></div>
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	30924000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	30897000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	28000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	1000	USD
CY2012	pcrx	Number Of Major Customers NumberOfMajorCustomers	4	item
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30332000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16437000	shares
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	574000	shares
CY2011	us-gaap	Royalty Revenue RoyaltyRevenue	3720000	USD
CY2011Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	862000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4081000	USD
CY2011Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	96000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5979000	USD
CY2011Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	287000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2017000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	12077000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33385000	USD
CY2011	us-gaap	Interest Paid InterestPaid	4739000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50719000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8282000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11603000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39116000	USD
CY2012	us-gaap	Depreciation Depreciation	3600000	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	31744000	USD
CY2010	us-gaap	Cost Of Goods Sold CostOfGoodsSold	11374000	USD
CY2011	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	800000	USD
CY2011	us-gaap	Depreciation Depreciation	2000000	USD
CY2010	us-gaap	Depreciation Depreciation	1800000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3208000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2300000	USD
CY2010	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2300000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2050000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	755000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	322000	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2824000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1635000	USD
CY2012Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	5924000	USD
CY2012Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	360000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9792000	USD
CY2011Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	3090000	USD
CY2011Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	345000	USD
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1287000	shares
CY2010	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8886000	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1437000	shares
CY2011	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	907000	USD
CY2011	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	51222000	USD
CY2011	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	6000	USD
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	15310000	USD
CY2012	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	395000	USD
CY2010	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	902000	USD
CY2011	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	1429000	USD
CY2012	us-gaap	Cost Of Revenue CostOfRevenue	32139000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	62231000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3395000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	4867000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2685000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	8745000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1325000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	83248000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83248000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	89150000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3631000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3891000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	3388000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1897000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1997000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	103954000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	103954000	USD
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16600000	USD
CY2010	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12200000	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	20700000	USD
CY2012	pcrx	Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax	0.50	pure
CY2012	pcrx	Period Within Which Cumulative Percentage Of Change In Ownership Occurs As Condition To Offset Taxable Income Or Tax PeriodWithinWhichCumulativePercentageOfChangeInOwnershipOccursAsConditionToOffsetTaxableIncomeOrTax	P3Y
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	420000	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	420000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	420000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	USD
CY2007Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	3300000	USD
CY2012	pcrx	Amortization Of Unfavorable Lease Accrual AmortizationOfUnfavorableLeaseAccrual	400000	USD
CY2011	pcrx	Amortization Of Unfavorable Lease Accrual AmortizationOfUnfavorableLeaseAccrual	400000	USD
CY2010	pcrx	Amortization Of Unfavorable Lease Accrual AmortizationOfUnfavorableLeaseAccrual	400000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5284000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5463000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	3464000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	201000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	14817000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4800000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	405000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4700000	USD
CY2010	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4500000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1300000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1400000	USD
CY2012	pcrx	Percentage Of Royalty On Sale Of Product PercentageOfRoyaltyOnSaleOfProduct	0.03	pure
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2493000	USD
CY2010	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4776000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5204537	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	4459232	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	745305	shares
CY2012Q4	pcrx	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Prior To Amendment ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPriorToAmendment	1729498	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	10.79
CY2012Q2	dei	Entity Public Float EntityPublicFloat	282645267	USD
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32656356	shares
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2011	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	15000	USD
CY2012	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	-239000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	770000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4776000	USD
CY2012	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	831000	USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1000	USD
CY2012	pcrx	Stock Issued During Period Value Follow On Public Offering Issues StockIssuedDuringPeriodValueFollowOnPublicOfferingIssues	62855000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	4776000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	224000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2239000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10832000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	59000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1386000	USD
CY2012	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	1076000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-106000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-16778000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18257000	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
CY2012	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	54047000	USD
CY2012	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	53120000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	870000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	12000	USD
CY2012	us-gaap	Use Of Estimates UseOfEstimates	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <p style="FONT-FAMILY: times"><font size="2"><b><i>Use of Estimates</i></b></font></p> <p style="FONT-FAMILY: times"><font size="2">        The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, the valuation of assets acquired, impairment of long-lived assets, goodwill, stock-based compensation and valuation of deferred tax assets. The Company's critical accounting policies are those that are both most important to the Company's consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</font></p></div>
CY2012	pcrx	Amount Received In Lockbox Restricted For Payment Of Royalty Interest AmountReceivedInLockboxRestrictedForPaymentOfRoyaltyInterest	2500000	USD
CY2012	pcrx	Payment Period Of Royalty Interest From Restricted Amount In Lockbox PaymentPeriodOfRoyaltyInterestFromRestrictedAmountInLockbox	P12M
CY2012Q4	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	823000	USD
CY2012Q4	pcrx	Royalty Interest Obligation Noncurrent RoyaltyInterestObligationNoncurrent	857000	USD
CY2011Q4	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	28332000	USD
CY2012Q4	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	26871000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-48383000	USD
CY2012	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	item
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	8297000	USD
CY2010	us-gaap	Royalty Revenue RoyaltyRevenue	3705000	USD
CY2011	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	1815000	USD
CY2010	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	675000	USD
CY2012	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	10339000	USD
CY2012	us-gaap	Repayments Of Debt RepaymentsOfDebt	26250000	USD
CY2012	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1365000	USD
CY2011Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	29970000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	25000	USD
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	10000	USD
CY2012	pcrx	Beginning Period Prior To Product Expiration Allowed For Returning Product BeginningPeriodPriorToProductExpirationAllowedForReturningProduct	P6M
CY2012	pcrx	Period After Product Expiration Upto Which Product Is Allowed To Be Returned PeriodAfterProductExpirationUptoWhichProductIsAllowedToBeReturned	P12M
CY2012Q4	pcrx	Inventory Valuation Reserve Of Product InventoryValuationReserveOfProduct	300000	USD
CY2012	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
CY2011	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6895000	USD
CY2010	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7640000	USD
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	27500000	USD
CY2012	pcrx	Class Of Warrant Or Right Value Of Warrant Issued With Debt ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt	1354000	USD
CY2011Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	674000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2012Q4	pcrx	Goodwill Recorded For Earn Out Payments GoodwillRecordedForEarnOutPayments	300000	USD
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2309000	USD
CY2011Q4	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	2756000	USD
CY2012Q4	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	1680000	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1062000	USD
CY2011	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1644000	USD
CY2010	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	146000	USD
CY2011Q4	pcrx	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	19211000	USD
CY2012Q4	pcrx	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	27500000	USD
CY2011Q4	us-gaap	Long Term Debt LongTermDebt	25576000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	25191000	USD
CY2012	us-gaap	Inventory Write Down InventoryWriteDown	200000	USD
CY2012Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	1873000	USD
CY2011Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	900000	USD
CY2010	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1523000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4352000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1920000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	511000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2569000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	972000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25191000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3720000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2275000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	298317000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-232520000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27000	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2000	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	18191000	USD
CY2012	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	18390000	USD
CY2012	us-gaap	Royalty Revenue RoyaltyRevenue	2503000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9937000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46306000	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	275000	USD
CY2012	us-gaap	Interest Expense InterestExpense	1807000	USD
CY2012	us-gaap	Royalty Expense RoyaltyExpense	278000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-111000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	15000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-52269000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43313000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27149000	USD
CY2012	pcrx	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	100000	USD
CY2012	pcrx	Debt Issuance On Issuance Of Warrants Value DebtIssuanceOnIssuanceOfWarrantsValue	1354000	USD
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0084	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0184	pure
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	15000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	15000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	12000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	27000	USD
CY2012Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	162885	shares
CY2012Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	10.97
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	490464	shares
CY2011Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	527656	shares
CY2011Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	10.22
CY2011Q3	us-gaap	Net Rentable Area NetRentableArea	13000
CY2012Q4	us-gaap	Net Rentable Area NetRentableArea	106000
CY2012Q2	pcrx	Management Agreement Contract Sum ManagementAgreementContractSum	7700000	USD
CY2012Q4	pcrx	Minimum Age Of Pediatric Patients To Study Exparel MinimumAgeOfPediatricPatientsToStudyEXPAREL	12	item
CY2012Q4	pcrx	Maximum Age Of Pediatric Patients To Study Exparel MaximumAgeOfPediatricPatientsToStudyEXPAREL	18	item
CY2012Q4	pcrx	Age Of Children Pediatric Patients To Study Exparel AgeOfChildrenPediatricPatientsToStudyEXPAREL	2	item
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	81000	USD
CY2011	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	52619000	USD
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	2100000	shares
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2011	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	22649000	USD
CY2013Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	120000000	USD
CY2011Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6000000	shares
CY2011Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37100000	USD
CY2011Q4	pcrx	Stock Issued During Period Shares Follow On Public Offering Issues StockIssuedDuringPeriodSharesFollowOnPublicOfferingIssues	8050000	shares
CY2012Q2	pcrx	Stock Issued During Period Shares Follow On Public Offering Issues StockIssuedDuringPeriodSharesFollowOnPublicOfferingIssues	6900000	shares
CY2012Q2	us-gaap	Share Price SharePrice	9.75
CY2012Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62900000	USD
CY2011Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49000000	USD
CY2012Q4	pcrx	Common Stock Shares Resulting From Cashless Exercise Of Warrants CommonStockSharesResultingFromCashlessExerciseOfWarrants	67279	shares
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3500	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3500	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3500	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0673	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0398	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0775	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3962	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3827	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4477	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0000	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0013	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0018	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2010	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0211	pure
CY2012Q4	pcrx	Operating Loss Carryforwards Related To Stock Based Compensation OperatingLossCarryforwardsRelatedToStockBasedCompensation	2200000	USD
CY2011	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	400000	USD
CY2012	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	400000	USD

Files In Submission

Name	View Source	Status
0001047469-13-002336-index-headers.html	Edgar Link	pending
0001047469-13-002336-index.html	Edgar Link	pending
0001047469-13-002336.txt	Edgar Link	pending
0001047469-13-002336-xbrl.zip	Edgar Link	pending
a2213236z10-k.htm	Edgar Link	pending
a2213236zex-10_47.htm	Edgar Link	pending
a2213236zex-10_48.htm	Edgar Link	pending
a2213236zex-21_1.htm	Edgar Link	pending
a2213236zex-23_1.htm	Edgar Link	pending
a2213236zex-31_1.htm	Edgar Link	pending
a2213236zex-31_2.htm	Edgar Link	pending
a2213236zex-32_1.htm	Edgar Link	pending
a2213236zex-32_2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g811854.jpg	Edgar Link	pending
pcrx-20121231.xml	Edgar Link	completed
pcrx-20121231.xsd	Edgar Link	pending
pcrx-20121231_cal.xml	Edgar Link	unprocessable
pcrx-20121231_def.xml	Edgar Link	unprocessable
pcrx-20121231_lab.xml	Edgar Link	unprocessable
pcrx-20121231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira BioSciences, Inc. Stock $pcrx

2011 Q4 Form 10-K Financial Statement

#000104746913002336 Filed on March 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira BioSciences, Inc. Stock $pcrx

2011 Q4 Form 10-K Financial Statement

#000104746913002336 Filed on March 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira BioSciences, Inc. Stock $pcrx